GARY PETERSON: Open Payments
NPI 1629147731 · TEMECULA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 25 payments from 13 companies in 2025. Trend: 2023 $1,357 · 2024 $1,415 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $385 |
| Regeneron Healthcare Solutions, Inc. | 7 | $175 |
| MERZ NORTH AMERICA, INC. | 2 | $62 |
| ABBVIE INC. | 2 | $41 |
| Organon LLC | 1 | $37 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $36 |
| LEO Pharma Inc. | 1 | $29 |
| Janssen Biotech, Inc. | 1 | $27 |
| Galderma Laboratories, L.P. | 1 | $25 |
| ConvaTec Inc. | 1 | $24 |
Products named: DUPIXENT, Xeomin, SKYRIZI, VTAMA, ILUMYA, ADBRY, TREMFYA, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
